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(engagement or measurement) and the focus of the article (health care, research, 
or teaching). Results: Our search identified 5051 publications from 1966-2013. We 
found a steep increase in the term’s use in recent decades. In the 1960s, ‘70s, and 
‘80s, < 50 articles were identified per decade. The number increased to > 350 in the 
90s, > 1550 in the 2000s and > 3000 in the 2010s. The vast majority (> 80%) of publica-
tions from the 1960s-2009 focused on patient engagement. However, from 2010-2013, 
the focus was equally split between engagement and measurement of PROs. From 
1966-2013, articles reporting original research increased from 17% to 90%. In early 
decades, qualitative research proliferated, whereas research since 2010 employed 
more quantitative epidemiological methods. There was also a notable shift from a 
single-disciplinary approach in the early decades to a multidisciplinary approach in 
the later decades. ConClusions: Since its introduction in scientific literature, the 
term patient-centered has flourished, with tremendous increases noted in the last 
decade. The concept has evolved from purely patient engagement to encompass both 
engagement and measurement of PROs and from qualitative to more rigorous scien-
tific methods. These findings are congruent with the current personalized-medicine 
approach that characterizes the health care industry today.
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objeCtives: The Hospital Consumer Assessment of Healthcare Providers and 
Systems (HCAHPS) survey captures patient satisfaction across 8 dimensions. CMS 
compares a facility’s most positive rating in each dimension (“top-box”) against 
three scores calculated from the national sample during a baseline period. Pain 
management is the only HCAHPS dimension directly related to a patient’s medical 
condition while concurrently influencing overall patient experience and satisfac-
tion. This study utilizes CMS data and HCAPHS survey results to evaluate current 
HCAHPS pain measures across facilities, and the potential benefit to overall HCAHPS 
scores by improving pain management in an inpatient setting. Methods: Baseline 
scores (low, middle, and high) from FY2013 through FY2016 were collected and 
evaluated for trends and impact on performance scores. A set of hospitals was 
selected based on participation in CMS data collection and HCAHPS survey admin-
istration. The average hospital domain scores were tabulated for all 8 dimensions 
for FY2013 and FY2014. A direct comparison was made between the changes in pain 
management dimension and all other dimensions. Results: Between FY2013 and 
FY2014 the pain management middle and high baseline scores will increase by 0.3% 
and 0.03% while the other 7 dimensions will increase on average, 1.0% and 0.4% 
respectively. Mean “top-box “ratings between FY2013-2014 changed by less than 
1% across all dimensions. The disparity in baseline scores over the same period 
led to a change in pain dimension scores by 3%, while the other 7 dimensions saw 
performance scores change in the range of 2% - > 10%. ConClusions: This analysis 
illustrates that changes to the baseline scores may have a significant impact on 
HCAHPS performance scores. As a result, proportional improvement in pain scores 
will disproportionately increase overall HCAHPS scores compared with the other 
7 dimensions, indicating an increased importance of adequate pain management 
on overall patient satisfaction and Medicare payment.
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objeCtives: Identify the main methodologies used to include patients’ prefer-
ences in the decision making process to determine the content of health benefit 
plans. Methods: We systematically searched electronic databases (MEDLINE, 
EMBASE, The Campbell Collaboration, JStor, Health System Evidence, DoPHER and 
LILACS) for studies that were published from the inception of the databases to 
September 16 2013. We excluded editorials, letters to the editor, communications, 
abstracts and any article related to preferences for particular technologies or stud-
ies describing decisions about specific diseases. Results: We found 1.868 non-
duplicate citations in the electronic search; 33 were assessed for eligibility and 
finally, 12 studies were included in the analysis (3 reviews and 9 individual studies). 
The reviews concluded that it is important to use simple, objective and inclusive 
methods to include patients’ preferences in decision making processes but don’t 
recommend any specific methodology. The other studies used methodologies favor-
ing public engagement and public participation, citizens’ jury, conjoint analysis, 
discrete choice experiment method and CHAT (Choosing Healthplans All Together). 
These studies were mainly conducted in High Income Countries (United States, 
Germany, Canada, UK and Hungary). CHAT was the methodology most commonly 
used because it is an exercise that patients understand easily, and researchers 
recognize as practical and objective. ConClusions: There is a growing interest 
in public engagement in priority setting in health. The methods and characteris-
tics of the studies evaluating methodologies used to include patients’ preferences 
in the decision making process to determine the content of health benefit plans 
varied, and it is difficult to make comparisons. Some methodologies such as con-
joint analysis methods might need more time to develop. Researchers believe it is 
important that the methodologies are easy for patients to understand to facilitate 
their participation.
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objeCtives: The study determines socio-economic factors that influence the likeli-
hood of a married woman in Indonesia on contraceptive choice. Methods: The 
given no instruction whether to consider income. Two studies reported significantly 
lower proportions (Sweden: 4%; United States: 15%), while 1 study a higher propor-
tion (Japan: 77%). Differences in study population (students versus general), health 
state severity, and utility elicitation method (time trade off versus visual analogue 
scale) may explain conflicting results. The impact of cultural attitudes towards work 
and the social security net (e.g. wage replacement rates) is not clear. No published 
studies shed light on whether respondents consider income loss when assigning 
utilities to the EQ-5D or other widely-used generic health tariffs. ConClusions: 
In many studies reviewed, a large proportion of respondents stated that they did 
not consider income loss during utility elicitation, suggesting income loss is not 
fully captured in health state valuations. Further research is needed to determine 
whether productivity losses are fully captured in QoL measurements for health 
scales such as the EQ-5D, or if the economic value of work loss should be included 
explicitly in cost-effectiveness analyses.
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objeCtives: This paper explores some ethical issues that may arise in the con-
text of generic and therapeutic substitution by evaluating patients’ awareness and 
understanding of drug substitution. Methods: A literature review and a survey 
of a total of 163 patients using a questionnaire containing 36 questions. Results: 
Majority of patients had a kidney transplant for more than a year ago and were 
highly educated. Overall key findings concluded that 84% of patients were aware 
of the availability of generic medicines, 70% understood the term “generic” and 
“branded” in relation to medicines and 54% were aware of generic substitution 
practice. However, 75% did not know if they were taking generic medicines and 84% 
felt that generics were not equivalent or only equivalent sometimes, and they were 
uncertain that generics had the same quality as branded medicines. Of patients on 
generics, 66% were dissatisfied or uncertain about their satisfaction concerning 
generic medicines and 55% experienced noticeable differences between the branded 
and generic medicines mostly in the packaging, shape, colour or taste and felt that 
the branded medicines are more effective than their counterpart generics. Of these, 
75% admitted that adapting to these differences was problematic. This practice has 
been considered ethical on the basis of the presumption that the cheaper drug is 
not inferior to the more expensive one and the premise that any saving that does 
not compromise the quality of care is ethical. Indeed, under such circumstances 
substitution raises no ethical problem whatsoever. ConClusions: Many patients 
are distrustful of generics because they consider these drugs as being less expensive, 
less effective and associated with increased adverse events. The lack of transparency 
around generic substitution is of concern and might lead to confusion or worry on 
the patients’ side. Promoting generic and therapeutic substitution on economic 
grounds alone is potentially dangerous and unethical.
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objeCtives: An important industry topic is the utilization of mixed PRO modes 
in clinical trials. Using mixed modes may be beneficial for sponsors, but there is a 
lack of evidence supporting that data from different modes renders equivalence 
across modes. Given the industry’s interest in mixed modes, a qualitative research 
investigation was done to see if patients would be accepting if mixed modes were 
introduced into clinical trials. Methods: A global internet-based survey was 
administered to patients who participated in at least 1 trial including patient diaries 
in the past 2 years. The survey included a qualitative section that asked patients 
to explain how attractive the option to utilize several different modes of patient 
diaries would be versus one mode alone in future trials. Responses were examined 
and placed into categories for analysis. Results: 346 patients provided analyzable 
responses. 67.1% indicated they favored multiple modes, 29.5% were against; 2.9% 
neutral, and 0.6% undecided. For those favoring mixed modes, 41.4% indicated that 
they liked options/choices, 19.4% indicated that it would be easier/more convenient, 
13.4% indicated being attracted to choosing their preferred mode, 12.9% indicated 
that it would allow for better access, and 12.9% found the flexibility to be attractive. 
For those who were against, 31.4% indicated that they preferred using one mode, 
28.4% were interested only in using their preferred mode, 20.6% indicated it would 
be confusing, and 19.6% indicated it would be more complicated. ConClusions: 
Results show that many patients would be accepting of mixed modes, but the 
acceptance is not unanimous. Mixed modes may be a part of future clinical studies 
if equivalence evidence is established. By examining responses of those against 
mixed modes, patients’ concerns can be identified and addressed. Common mes-
sages identified include keeping the modes easy to use and selecting proper choice 
of modes for administration.
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objeCtives: In today’s health care arena, the term “patient-centered” is typically used 
to describe either: 1) the engagement of patients in managing their health or 2) the 
measurement of patient-reported outcomes (PROs). The objective of this study was 
to explore the evolution of the patient-centered concept as reported in the scientific 
literature. Methods: We searched EMBASE for articles written in English between 
1950-2013 with ‘patient-centered’ in the title or abstract. We examined trends in the 
concept’s use over time by graphing the number of publications by year. We selected 
a random sample of 10 articles within each decade and captured data on the context 
